Spect Inc.

Spect Inc. is a technology company focused on enhancing eye care accessibility and early disease detection through its comprehensive clinical ecosystem. Their solutions aim to prevent blindness and improve patient outcomes in vision care. Founded in 2017, Spect Inc.

is based in Palo Alto, US. The company specializes in eye care solutions, offering a platform that integrates electronic medical records and health records for effective data management. The founders, Michael Leung and Michael Ricci, have a background in health technology, with Michael Ricci currently serving as the CEO. Spect has successfully raised USD 3.

5 mn in Seed funding as of November 30, 2021, co-led by AME Cloud Ventures and other investors. This funding round represents the total amount raised by the company, which has completed three deals to date. Spect offers a platform designed to enhance eye care accessibility and improve early detection of eye diseases, ultimately aiming to prevent blindness. Their clinical ecosystem integrates electronic medical records (EMR) and electronic health records (EHR), ensuring streamlined data management while adhering to strict HIPAA compliance and SOC 2 Type 1 certification standards.

The primary users include healthcare providers and patients, particularly those affected by diabetes and other vision impairment conditions. Spect is committed to delivering solutions to underserved communities, reaching both urban and rural populations in the United States to ensure eye care remains accessible. Spect's revenue model is structured around partnerships and direct transactions with healthcare providers and organizations. The company generates income through subscription-based services that allow clients to utilize its platform for patient management and eye disease detection.

Pricing plans are tailored to individual clients, varying based on implementation scale and specific features. Their offerings focus on data security and user-friendly interfaces for both healthcare professionals and patients. In November 2021, Spect Inc. raised USD 3.

5 mn in Seed funding to enhance its AI capabilities, expand its team, and increase diagnostic access and partnerships with clinics and enterprise health systems. The company plans to launch new products focused on improving diagnostic tools in the coming years. Additionally, Spect is targeting the expansion of its services into new geographic regions, specifically underserved markets across the United States, to enhance their reach and improve eye care accessibility.